Biogaia AB Sponsored ADR logo

Biogaia AB Sponsored ADR (BIOGY)

Market Closed
16 Dec, 20:00
OTC PINK OTC PINK
$
10. 35
0
0%
$
960.35M Market Cap
- P/E Ratio
2.54% Div Yield
0 Volume
- Eps
$ 10.35
Previous Close
Day Range
10.35 10.35
Year Range
8.79 11.46
Want to track BIOGY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 54 days

Summary

BIOGY closed yesterday higher at $10.35, an increase of 0% from Monday's close, completing a monthly decrease of -0.28% or $0.03. Over the past 12 months, BIOGY stock gained 3.5%.
BIOGY pays dividends to its shareholders, with the most recent payment made on May 29, 2025. The next estimated payment will be in In 5 months on May 29, 2026 for a total of $0.70792.
The last earnings report, released on Oct 20, 2025, exceeded the consensus estimates by 0.07%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports. The next scheduled earnings report is due on Feb 10, 2026.
Biogaia AB Sponsored ADR has completed 1 stock splits, with the recent split occurring on May 26, 2022.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

BIOGY Chart

Biogaia AB Sponsored ADR (BIOGY) FAQ

What is the stock price today?

The current price is $10.35.

On which exchange is it traded?

Biogaia AB Sponsored ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is BIOGY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.54%.

What is its market cap?

As of today, the market cap is 960.35M.

When is the next earnings date?

The next earnings report will release on Feb 10, 2026.

Has Biogaia AB Sponsored ADR ever had a stock split?

Biogaia AB Sponsored ADR had 1 splits and the recent split was on May 26, 2022.

Biogaia AB Sponsored ADR Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Theresa P. Agnew CEO
OTC PINK Exchange
09072J102 CUSIP
SE Country
224 Employees
9 May 2025 Last Dividend
26 May 2022 Last Split
- IPO Date

Overview

BioGaia AB (publ) is a globally recognized healthcare company specializing in the development and distribution of probiotic products. Established in 1990, the company has its headquarters in Stockholm, Sweden. It operates through three primary segments: Pediatrics, Adult Health, and Other. BioGaia has carved a niche for itself in the healthcare industry by focusing on delivering probiotic products that cater to different age groups and health needs. Its distribution network spans worldwide, leveraging both external partners and proprietary channels to reach a diverse customer base.

Products and Services

  • Pediatrics Segment:

    Under its Pediatrics segment, BioGaia offers a range of probiotic products aimed at improving children's health. This includes probiotic drops, which are designed to be easy to administer to infants and young children; oral rehydration solutions, which provide essential electrolytes lost during bouts of diarrhea; gut health tablets tailored for slightly older children; and specific cultures used as ingredients in infant formulas. These products are developed to support the digestive systems of babies and children, enhancing overall health and wellbeing.

  • Adult Health Segment:

    The Adult Health segment focuses on products for grown-ups, including gut health tablets that help maintain a healthy digestive system; oral health lozenges designed to support the oral microbiome; and specific probiotic cultures used in a licensee's dairy products. These offerings target common adult health concerns, particularly those related to gut and oral health, providing natural, probiotic-based solutions.

  • Other Segment:

    Aside from its core probiotic products, BioGaia also engages in the provision of packaging solutions. This segment serves to support the company's main operations as well as offering these services to the wider market. It underscores BioGaia's commitment to delivering not just health solutions but also supporting the lifecycle of its products from production to consumer.

Contact Information

Address: Kungsbroplan 3
Phone: 46 8 55 52 93 00